Aroa Biosurgery Investor Relations Material
Latest events
H2 2025
Aroa Biosurgery
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aroa Biosurgery Limited
Access all reports
Aroa Biosurgery Limited develops and manufactures regenerative tissue repair products derived from extracellular matrix biomaterials. The company’s products are used in wound care, soft tissue reconstruction, and surgical applications. Aroa Biosurgery serves healthcare providers and medical institutions across international markets. The company is headquartered in Auckland, New Zealand, and its shares are listed on the ASX.
Key slides for Aroa Biosurgery Limited
H2 2025
Aroa Biosurgery Limited
H2 2025
Aroa Biosurgery Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ARX
Country
🇦🇺 Australia